Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3683932
Reference Type
Journal Article
Title
Disruption of Retinol (Vitamin A) Signaling by Phthalate Esters: SAR and Mechanism Studies
Author(s)
Chen, Y; Reese, DH
Year
2016
Is Peer Reviewed?
1
Journal
PLoS ONE
EISSN:
1932-6203
Publisher
Public Library of Science
Volume
11
Issue
8
Page Numbers
e0161167
Language
English
PMID
27532513
DOI
10.1371/journal.pone.0161167
Web of Science Id
WOS:000381487600069
URL
https://search.proquest.com/docview/1815695137?accountid=171501
Exit
Abstract
A spectrum of reproductive system anomalies (cryptorchidism, hypospadias, dysgenesis of Wolffian duct-derived tissues and prostate, and reduced sperm production) in male rats exposed in utero to phthalate esters (PEs) are thought to be caused by PE inhibition of fetal testosterone production. Recently, dibutyl and dipentyl phthalate (DBuP, DPnP) were shown to disrupt the retinol signaling pathway (RSP) in mouse pluripotent P19 embryonal carcinoma cells in vitro. The RSP regulates the synthesis and cellular levels of retinoic acid (RA), the active metabolite of retinol (vitamin A). In this new study, a total of 26 di- and mono-esters were screened to identify additional phthalate structures that disrupt the RSP and explore their mechanisms of action. The most potent PEs, those causing > 50% inhibition, contained aryl and cycloalkane groups or C4-C6 alkyl ester chains and were the same PEs reported to cause malformations in utero. They shared similar lipid solubility; logP values were between 4 and 6 and, except for PEs with butyl and phenyl groups, were stable for prolonged periods in culture. Mono- and cognate di-esters varied in ability to disrupt the RSP; e.g., DEHP was inactive but its monoester was active while DBuP was active yet its monoester was inactive. DBuP and dibenzyl phthalate both disrupted the synthesis of RA from retinol but not the ability of RA to activate gene transcription. Both PEs also disrupted the RSP in C3H10T1/2 multipotent mesenchymal stem cells. Based on this in vitro study showing that some PEs disrupt retinol signaling and previous in vivo studies that vitamin A/RA deficiency and PEs both cause strikingly similar anomalies in the male rat reproductive system, we propose that PE-mediated inhibition of testosterone and RA synthesis in utero are both causes of malformations in male rat offspring.
Keywords
Cell Line; Dibutyl Phthalate/pharmacology; Diethylhexyl Phthalate/pharmacology; Environmental Exposure; Fetus/drug effects; Mesenchymal Stem Cells/metabolism; Mice, Inbred C3H; Phthalic Acids/chemistry/pharmacology; Testis/growth & development; Testosterone/biosynthesis; Tretinoin/metabolism; Vitamin A/metabolism; 11103-57-4; 131-18-0; 2286E5R2KE; 3XMK78S47O; 5688UTC01R; 6O7F7IX66E; C42K0PH13C
Tags
IRIS
•
Dibutyl Phthalate (DBP)
Additional Strategies
March 2017 Search strategy results
Studies with Supporting Data
Mechanistic and genotoxicity studies
•
Diisobutyl Phthalate (DIBP) Final
Additional Search Strategies
WoS forward search
Studies with Supporting Data
Mechanistic and genotoxicity studies
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity